About the Medical Review Board

Health League is an independent medical reference encyclopedia dedicated to providing accurate, evidence-based information about GLP-1 receptor agonist medications. Our mission is to make complex pharmacological and insurance information accessible to patients, caregivers, and healthcare professionals.

Editorial Standards

Every article published on Health League undergoes a multi-stage review process:

1. Primary Research — Content is developed from FDA prescribing information, published clinical trial data, and peer-reviewed medical literature.
2. Clinical Review — Articles are reviewed by board-certified healthcare professionals for medical accuracy and appropriate context.
3. Editorial Review — Final review ensures clarity, readability, and adherence to our style guide.
4. Periodic Updates — All content is reassessed on a quarterly basis to reflect new clinical data, formulary changes, and FDA safety communications.

Our Coverage

The Health League Medical Encyclopedia currently maintains comprehensive reference articles across two primary domains:

• Side Effects — Documented adverse effects of GLP-1 receptor agonists including Ozempic (semaglutide), Mounjaro (tirzepatide), Wegovy, Zepbound, and Rybelsus, sourced from clinical trials and post-marketing surveillance.
• Insurance Coverage — Detailed formulary analysis for major U.S. health insurers including Medicare, Medicaid, Aetna, Cigna, UnitedHealthcare, Anthem, Humana, Blue Cross Blue Shield, Kaiser Permanente, TRICARE, and Ambetter.

Sources and Citations

Health League articles cite primary sources including:

• FDA-approved prescribing information and medication guides
• Published results from SURPASS, SURMOUNT, SUSTAIN, and STEP clinical trial programs
• FDA Adverse Event Reporting System (FAERS) data
• Centers for Medicare & Medicaid Services (CMS) formulary guidance
• American Diabetes Association Standards of Care
• Insurer formulary and prior authorization documents

Contact

Health League is committed to accuracy. If you identify an error or have a correction to suggest, please contact our editorial team. We review all submissions and update articles as appropriate based on available evidence.